Opinion

Video

Managing Adverse Events Associated with HE Therapies

Ralph J. Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
1 expert in this video
Related Content
Neuron cells, brain activity -- Image credit: Matthieu | stock.adobe.com
September 17th 2025

Integration of DBS Shows Promise Identifying Dysfunctional Brain Circuits, Treating Brain Disorders

Gillian McGovern, Associate Editor
Elderly man putting together a puzzle -- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
September 17th 2025

Study Results Highlight Importance of Overcoming Stigma When Addressing Brain Health

Gillian McGovern, Associate Editor
3d illustration of human body organ -- Image credit: PIC4U | stock.adobe.com
September 17th 2025

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health

Gillian McGovern, Associate Editor
Burgundy ribbon for multiple myeloma cancer awareness
September 17th 2025

Individuals With Obesity More Likely to Have MGUS, A Multiple Myeloma Precursor

Gillian McGovern, Associate Editor
FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer
September 17th 2025

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

Gillian McGovern, Associate Editor
Image credit: Dglimages | stock.adobe.com
September 17th 2025

Study Data Show Telemedicine Endocrinology Care Not as Effective as In-Person Care

Erin Hunter, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.